Drug Profile
CH 13584
Alternative Names: KHL 8425Latest Information Update: 07 Sep 2000
Price :
$50
*
At a glance
- Originator Chinoin
- Class Antiallergics; Antiasthmatics; Antitussives; Bronchodilators
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bronchitis
Most Recent Events
- 07 Sep 2000 Discontinued-Preclinical for Bronchitis in Hungary (Unknown route)
- 30 Aug 1999 Sanofi and Synthélabo have now merged to form Sanofi-Synthélabo
- 05 Feb 1997 The new name for KHL 8425 is CH 13584